Diana Lennon

4.7k total citations
113 papers, 3.2k citations indexed

About

Diana Lennon is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Diana Lennon has authored 113 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Public Health, Environmental and Occupational Health, 56 papers in Epidemiology and 32 papers in Infectious Diseases. Recurrent topics in Diana Lennon's work include Streptococcal Infections and Treatments (55 papers), Bacterial Infections and Vaccines (30 papers) and Pneumonia and Respiratory Infections (26 papers). Diana Lennon is often cited by papers focused on Streptococcal Infections and Treatments (55 papers), Bacterial Infections and Vaccines (30 papers) and Pneumonia and Respiratory Infections (26 papers). Diana Lennon collaborates with scholars based in New Zealand, Australia and United States. Diana Lennon's co-authors include Joanna Stewart, Daniel A. Haas, Diana Martin, Philipp Oster, Lesley Voss, Jane O’Hallahan, Kim Mulholland, Michael G. Baker, S Reid and Susan J. Walker and has published in prestigious journals such as The Lancet, Circulation and Clinical Infectious Diseases.

In The Last Decade

Diana Lennon

111 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diana Lennon New Zealand 33 1.6k 1.3k 1.0k 992 224 113 3.2k
J.‐P. Stahl France 32 1.9k 1.2× 628 0.5× 1.2k 1.2× 413 0.4× 235 1.0× 226 3.8k
Keith R. Powell United States 29 2.0k 1.2× 750 0.6× 703 0.7× 294 0.3× 116 0.5× 91 3.7k
Raymond A. Smego United States 30 1.1k 0.7× 589 0.4× 1.0k 1.0× 141 0.1× 159 0.7× 89 3.3k
Georges Peter United States 21 1.1k 0.7× 557 0.4× 623 0.6× 274 0.3× 95 0.4× 72 2.3k
Adnan S. Dajani United States 32 2.8k 1.7× 2.4k 1.8× 1.7k 1.7× 388 0.4× 507 2.3× 92 5.8k
D.C. Shanson United Kingdom 29 1.2k 0.8× 479 0.4× 1.5k 1.5× 127 0.1× 263 1.2× 120 2.8k
Shelly McNeil Canada 42 4.3k 2.6× 639 0.5× 1.7k 1.7× 823 0.8× 360 1.6× 193 6.5k
Adelisa L. Panlilio United States 23 1.0k 0.6× 349 0.3× 1.9k 1.9× 177 0.2× 251 1.1× 34 3.0k
James W. Bass United States 34 1.4k 0.9× 824 0.6× 1.0k 1.0× 624 0.6× 100 0.4× 115 3.5k
Itzhak Brook United States 28 678 0.4× 745 0.6× 757 0.8× 154 0.2× 185 0.8× 71 2.5k

Countries citing papers authored by Diana Lennon

Since Specialization
Citations

This map shows the geographic impact of Diana Lennon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Lennon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Lennon more than expected).

Fields of papers citing papers by Diana Lennon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Lennon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Lennon. The network helps show where Diana Lennon may publish in the future.

Co-authorship network of co-authors of Diana Lennon

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Lennon. A scholar is included among the top collaborators of Diana Lennon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Lennon. Diana Lennon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lennon, Diana, et al.. (2021). Microbiology of septic arthritis in young Auckland children. Journal of Paediatrics and Child Health. 58(2). 326–331. 6 indexed citations
3.
Baker, Michael G., Jason Gurney, Jane Oliver, et al.. (2019). Risk Factors for Acute Rheumatic Fever: Literature Review and Protocol for a Case-Control Study in New Zealand. International Journal of Environmental Research and Public Health. 16(22). 4515–4515. 48 indexed citations
4.
Lennon, Diana, et al.. (2017). First Presentation Acute Rheumatic Fever is Preventable in a Community Setting. The Pediatric Infectious Disease Journal. 36(12). 1113–1118. 21 indexed citations
5.
Webb, Rachel, et al.. (2017). Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening.. PubMed. 130(1457). 50–57. 12 indexed citations
6.
Reed, Peter, et al.. (2017). Is a rheumatic fever register the best surveillance tool to evaluate rheumatic fever control in the Auckland region?. PubMed. 130(1460). 48–62. 6 indexed citations
7.
Vogel, Alison, Diana Lennon, Emma Best, & Alison Leversha. (2016). Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges.. PubMed. 129(1443). 77–83. 12 indexed citations
8.
Firestone, Ridvan, et al.. (2016). Antimicrobial stewardship using pharmacy data for the nurse-led school-based clinics in Counties Manukau District Health Board for management of group A streptococcal pharyngitis and skin infection.. PubMed. 129(1435). 29–38. 5 indexed citations
9.
Williamson, Deborah A., Stephen Ritchie, Mark Thomas, et al.. (2016). Persistence, Discordance and Diversity of Staphylococcus aureus Nasal and Oropharyngeal Colonization in School-aged Children. The Pediatric Infectious Disease Journal. 35(7). 744–748. 21 indexed citations
10.
Webb, Rachel, Lesley Voss, Sally Roberts, et al.. (2014). Infective Endocarditis in New Zealand Children 1994–2012. The Pediatric Infectious Disease Journal. 33(5). 437–442. 19 indexed citations
11.
Williamson, Deborah A., Stephen Ritchie, Sally Roberts, et al.. (2014). Clinical and molecular epidemiology of community-onset invasiveStaphylococcus aureusinfection in New Zealand children. Epidemiology and Infection. 142(8). 1713–1721. 15 indexed citations
12.
Wilson, Nigel, et al.. (2013). New Zealand guidelines for the diagnosis of acute rheumatic fever: small increase in the incidence of definite cases compared to the American Heart Association Jones criteria.. PubMed. 126(1379). 50–9. 11 indexed citations
13.
Webb, Rachel, Nigel Wilson, Diana Lennon, et al.. (2011). Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic. Cardiology in the Young. 21(4). 436–443. 62 indexed citations
14.
O’Hallahan, Jane, Diana Lennon, Philipp Oster, et al.. (2005). From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease. Vaccine. 23(17-18). 2197–2201. 38 indexed citations
15.
Butler, Jay C., Sue Crengle, James E. Cheek, et al.. (2001). Emerging Infectious Diseases Among Indigenous Peoples. Emerging infectious diseases. 7(7). 554–555. 30 indexed citations
16.
Grimwood, Keith, et al.. (2001). Late antenatal carriage of group B streptococcus. European Journal of Heart Failure. 12 Suppl 1. S1–380. 1 indexed citations
17.
Lennon, Diana, et al.. (1995). Control of whooping cough in New Zealand; slow progress.. PubMed. 108(1013). 495–7. 1 indexed citations
18.
Haas, Daniel A. & Diana Lennon. (1995). Local anesthetic use by dentists in Ontario.. PubMed. 61(4). 297–304. 27 indexed citations
19.
Voss, Lesley & Diana Lennon. (1994). Epidemiology, management, and prevention of meningococcal infections. Current Opinion in Pediatrics. 6(1). 23–28. 3 indexed citations
20.
Lennon, Diana, et al.. (1992). Yersinia arthritis versus acute rheumatic fever in a boy.. PubMed. 105(926). 12–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026